Article
What's the best way to monitor low-risk patients with a history of differentiated thyroid cancer?
- Author:
- Angela M. Albrecht, MD
- Christopher P. Paulson, MD
- Fran E. Kovach, MLIS, AHIP
Evidence-based answer: A recombinant human thyrotropin (rhTSH)-stimulated serum thyroglobulin (Tg) level alone is sufficient to monitor for...